1. Home
  2. PBM vs AZTR Comparison

PBM vs AZTR Comparison

Compare PBM & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • AZTR
  • Stock Information
  • Founded
  • PBM 1994
  • AZTR 2014
  • Country
  • PBM Canada
  • AZTR United States
  • Employees
  • PBM N/A
  • AZTR N/A
  • Industry
  • PBM
  • AZTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBM
  • AZTR Health Care
  • Exchange
  • PBM NYSE
  • AZTR Nasdaq
  • Market Cap
  • PBM 4.0M
  • AZTR 4.8M
  • IPO Year
  • PBM N/A
  • AZTR 2023
  • Fundamental
  • Price
  • PBM $0.11
  • AZTR $0.58
  • Analyst Decision
  • PBM
  • AZTR
  • Analyst Count
  • PBM 0
  • AZTR 0
  • Target Price
  • PBM N/A
  • AZTR N/A
  • AVG Volume (30 Days)
  • PBM 7.3M
  • AZTR 205.8K
  • Earning Date
  • PBM 11-02-2024
  • AZTR 11-12-2024
  • Dividend Yield
  • PBM N/A
  • AZTR N/A
  • EPS Growth
  • PBM N/A
  • AZTR N/A
  • EPS
  • PBM N/A
  • AZTR N/A
  • Revenue
  • PBM N/A
  • AZTR $408,200.00
  • Revenue This Year
  • PBM N/A
  • AZTR $494.75
  • Revenue Next Year
  • PBM N/A
  • AZTR N/A
  • P/E Ratio
  • PBM N/A
  • AZTR N/A
  • Revenue Growth
  • PBM N/A
  • AZTR 12.05
  • 52 Week Low
  • PBM $0.09
  • AZTR $0.46
  • 52 Week High
  • PBM $14.55
  • AZTR $68.40
  • Technical
  • Relative Strength Index (RSI)
  • PBM 36.62
  • AZTR 50.98
  • Support Level
  • PBM $0.10
  • AZTR $0.46
  • Resistance Level
  • PBM $0.12
  • AZTR $0.54
  • Average True Range (ATR)
  • PBM 0.01
  • AZTR 0.04
  • MACD
  • PBM 0.01
  • AZTR 0.02
  • Stochastic Oscillator
  • PBM 78.65
  • AZTR 86.30

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

Share on Social Networks: